Headinvest LLC Increases Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Headinvest LLC boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,997 shares of the exchange traded fund’s stock after purchasing an additional 235 shares during the period. Headinvest LLC’s holdings in SPDR S&P Biotech ETF were worth $450,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Atomi Financial Group Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 224.2% during the 4th quarter. Atomi Financial Group Inc. now owns 7,248 shares of the exchange traded fund’s stock worth $653,000 after acquiring an additional 5,012 shares during the period. SG Americas Securities LLC grew its holdings in shares of SPDR S&P Biotech ETF by 78.7% during the 4th quarter. SG Americas Securities LLC now owns 106,106 shares of the exchange traded fund’s stock worth $9,556,000 after acquiring an additional 46,718 shares during the period. Avior Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after acquiring an additional 307 shares during the period. Cornerstone Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $520,000. Finally, CX Institutional grew its holdings in shares of SPDR S&P Biotech ETF by 1.6% during the 4th quarter. CX Institutional now owns 12,196 shares of the exchange traded fund’s stock worth $1,098,000 after acquiring an additional 196 shares during the period.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $79.25 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $105.47. The business’s 50 day moving average price is $79.30 and its two-hundred day moving average price is $88.08. The company has a market capitalization of $4.99 billion, a price-to-earnings ratio of 11.47 and a beta of 0.91.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.